top of page
CGTI.png

Sandra Van Wetering

VP Process Science and Manufacturing at GammaDelta Therapeutics

Sandra van Wetering is an expert in the development and manufacturing of cell-based products, and has in-depth knowledge the regulatory strategies and processes involved in development of such products, in the context of the relevant EMA/FDA regulatory framework for Advanced Therapeutic Medical Products (ATMP's) and associated GMP guidelines. She holds a PhD in immunology and also has strong knowledge of clinical development and execution of clinical operations, in particular in immunotherapy. She has been working for over 9 years as the COO of DCPrime, a clinical stage company that develops off-the-shelf dendritic cell-based vaccines for a broad range of cancer types, based on its unique, proprietary technology platform, DCOne.

Share
  • LinkedIn
  • Youtube
  • X
  • Instagram
How we drive innovation
STORIES
MEETINGS
MEMBERS
Speakers
bottom of page